- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01644552
Positive Angle Kappa
October 30, 2019 updated by: University of Minnesota
Positive Angle Kappa: a Sign in Aniridia
Patients with aniridia have positive angle kappas.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
16
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota Dept of ophthalmlogy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 85 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients with aniridia
Description
Inclusion Criteria:
- patients with aniridia only
Exclusion Criteria:
- poor va
- PK,
- K-pro
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
---|
eye examinations
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
February 20, 2012
First Submitted That Met QC Criteria
July 18, 2012
First Posted (Estimate)
July 19, 2012
Study Record Updates
Last Update Posted (Actual)
November 1, 2019
Last Update Submitted That Met QC Criteria
October 30, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1004M80112
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aniridia
-
Clinical Research Consultants, Inc.HumanOptics AGRecruitingFull Aniridia | Partial AniridiaUnited States
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
University of MinnesotaRecruiting
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
PTC TherapeuticsCompletedAniridiaUnited States, Canada
-
University Hospital, MontpellierRecruiting
-
University College, LondonMedical Research Council; Moorfields Eye Hospital NHS Foundation TrustRecruiting
-
PTC TherapeuticsWithdrawn
-
National Eye Institute (NEI)Completed
-
University of California, Los AngelesCompleted